跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SANDOZ TRANDOLAPRIL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SANDOZ TRANDOLAPRIL
Authorized
STANDARD
SANDOZ TRANDOLAPRIL
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1afd950200d7b748
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
1afd950200d7b748
Drug Approval Canada Name
SANDOZ TRANDOLAPRIL
Product Name
SANDOZ TRANDOLAPRIL
Status
Marketed
Status Date
2018-07-12
Original Market Date
2018-07-12
Din
02325748
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.04
Atc Original
C09AA10 TRANDOLAPRIL
Atc Name
c 09 aa 10
Aig Number
0131524002
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
TRANDOLAPRIL
1 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1afd950200d7b748
Type
Standard
Back to Health Canada Approvals